Robbins LLP Is Investigating the Officers and Directors of American Renal Associates Holdings, Inc. (ARA) on Behalf of Shareholders
Robbins LLP is investigating whether certain officers and directors of American Renal Associates, Inc. (NYSE: ARA) breached their fiduciary duties to shareholders. On August 31, 2016, a class action complaint was filed against American Renal Associates (“ARA”) in the U.S. District Court for the Southern District of New York for alleged violations of the Securities Act of 1933 and the Securities Exchange Act of 1934. The complaint alleges that ARA engaged in a fraudulent scheme to steer patients away from qualified-for Medicare and Medicaid plans into more expensive Affordable Care Act plans to obtain greater reimbursement for the company’s dialysis services. ARA operates as a dialysis services provider in the U.S. and focuses exclusively on joint venture partnerships with physicians.
American Renal Associates Shareholders Have Legal Options
Concerned shareholders who would like more information about their rights and potential remedies can contact us via the form below and we will contact you directly.